Every week, an average of three in every ten adolescent elite athletes suffer an injury. Worst affected are young women, and the risk of injury increases with low self-esteem, especially in combination with less sleep and higher training volume and intensity, research from in Sweden shows.
The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one's own adipose stem cells are used to determine if they can repair partial thickness rotator cuff tears.
Except for increased anterior-posterior knee laxity, results from this study indicated female athletes and male athletes were not similar with regard to predictors for first-time noncontact ACL injury.
Most patients who underwent nonoperative treatment for rotator cuff tears had anatomic tear deterioration, with poorer functional outcomes found in large tear size increases and progression of muscle atrophy, according to results.